Conmed (CNMD) Income from Continuing Operations (2010 - 2026)
Conmed (CNMD) reported Income from Continuing Operations of 13828000.0 for Q1 2026, up 129.09% on a YoY basis from 6036000.0 in Q1 2025, and down 17.39% quarter-over-quarter from 16739000.0 in Q4 2025.
Conmed (CNMD) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Conmed has reported Income from Continuing Operations for 17 years, with the latest figure at 13828000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 129.09% year-over-year to 13828000.0; the trailing twelve-month figure through Mar 2026 stood at 54847000.0 (down 53.81% YoY), and the FY2025 full-year result was 47055000.0, down 64.47% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 13828000.0, down from 16739000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 48984000.0 in Q3 2024, with the low at 168291000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 10422588.24 across 5 years, with a median of 16739000.0 in 2025.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 1366.3% — and 2024, when it surged 983.51%.
- Conmed's Income from Continuing Operations stood at 26584000.0 in 2022, then advanced by 24.4% to 33071000.0 in 2023, then advanced by 2.07% to 33755000.0 in 2024, then slumped by 50.41% to 16739000.0 in 2025, then decreased by 17.39% to 13828000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 13828000.0 (Q1 2026), 16739000.0 (Q4 2025), and 2859000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Conmed | 994.72 Mn | 959.69 Mn | 183.45 Mn | 13.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.83 Mn |
| Dec 31, 2025 | 16.74 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 21.42 Mn |
| Mar 31, 2025 | 6.04 Mn |
| Dec 31, 2024 | 33.76 Mn |
| Sep 30, 2024 | 48.98 Mn |
| Jun 30, 2024 | 29.98 Mn |
| Mar 31, 2024 | 19.71 Mn |
| Dec 31, 2023 | 33.07 Mn |
| Sep 30, 2023 | 15.84 Mn |
| Jun 30, 2023 | 13.73 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 26.58 Mn |
| Sep 30, 2022 | 46.15 Mn |
| Jun 30, 2022 | -168.29 Mn |
| Mar 31, 2022 | 14.98 Mn |
| Dec 31, 2021 | 24.44 Mn |
| Sep 30, 2021 | 14.95 Mn |
| Jun 30, 2021 | 13.29 Mn |